CORDIS · 246543 · FP7
ETHFELLOWS ETH Zurich Postdoctoral Fellowship Program
Coordinator: EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (CH)
ETH Zurich applies for co-funding of its newly established ETH Fellowship program after it has been financed exclusively by ETH’s internal resources in a pilot phase. The program supports incoming fellowships for postdoctoral researchers on a competitive basis. The ETH Fellowship program aims at high-potential individuals primarily interested in following an academic career. Awardees will be offered an ETH employment contract with a standard postdoctoral salary for a maximum of two years. ETH Fellows will be also entitled to an annual individual travel and consumable budget and are expected t…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €5.0M toward a total project budget of €12.4M — a funding rate of 40%, with the remainder covered by the consortium partners. The project runs over approximately 5 years from 2011-03-01 to 2016-02-29.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from CH
see all →- HBP SGA1 — Human Brain Project Specific Grant Agreement 1720270 · H2020 · €89.0M
- HBP SGA2 — Human Brain Project Specific Grant Agreement 2785907 · H2020 · €88.0M
- ATTRACT2 — Breakthrough Innovation Programme for a Pan-European Detection and Imaging Eco-System – Phase-2101004462 · H2020 · €35.0M
- STEMBANCC — Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)115439 · FP7 · €26.0M
- IABC PROGRAMME — iABC Programme115721 · FP7 · €24.3M
- ULTRA-DD — Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery115766 · FP7 · €21.2M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the MC-COFUND funding scheme.
- What is the EU contribution?
- The European Commission contributes €5.0M toward a total project budget of €12.4M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (CH).
- What is the project timeline?
- The project runs from 2011-03-01 to 2016-02-29 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 246543.